Considering the high expression of PSMA on the cell membrane of PCa cells and based on the first urea-based compounds, several low-molecular-weight radiolabelled PSMA inhibitors have been developed to expand the diagnostic performance of nuclear medicine imaging for PCa detection. The gene discussed is FOLH1; the disease is posterior cortical atrophy.